Metrics to compare | 031860 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship Relationship031860PeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | 3.8x | 10.2x | |
PEG Ratio | 0.00 | 0.02 | 0.02 | |
Price/Book | 0.8x | 0.4x | 1.4x | |
Price / LTM Sales | 1.4x | 0.4x | 0.9x | |
Upside (Analyst Target) | - | −5.1% | 28.4% | |
Fair Value Upside | Unlock | 29.5% | 11.6% | Unlock |
DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset management; and commodity brokerage business. The company was formerly known as SU-Holdings Co.,Ltd. and changed its name to DHX Company Co., Ltd. in December 2024. DHX Company Co., Ltd. was founded in 1979 and is headquartered in Seoul, South Korea.